Accessibility helpSkip to navigationSkip to contentSkip to footer
  • Sign In
  • Subscribe
Open side navigation menuOpen search bar
Financial Times
SubscribeSign InmyFT
  • Home
  • World
    Sections
    • World Home
    • Global Economy
    • UK
    • US
    • China
    • Africa
    • Asia Pacific
    • Emerging Markets
    • Europe
    • War in Ukraine
    • Americas
    • Middle East & North Africa
    • Australia & NZ
    Most Read
    • Vladimir Putin plans meeting on Russian currency controls after rouble’s slide
    • US asks Iran to stop selling drones to Russia
    • Federal Reserve signals more scepticism over need for further rate rises
    • ‘Little Italy’: tourists flock to Albania’s low-cost resorts
    • Ukraine defies Russian threat as container ship leaves Odesa
  • UK
    Sections
    • UK Home
    • UK Economy
    • UK Politics
    • Brexit
    • UK Companies
    • Personal Finance
    Most Read
    • UK inflation slows to 6.8% in July as energy prices fall
    • Three more women allege misconduct by former Downing Street adviser Daniel Korski
    • UK rents rise at record pace as house price growth slows
    • England beat co-hosts Australia to reach Women’s World Cup final
    • British army’s £3.2bn battlefield radio ‘next procurement disaster’, MPs warn
  • Companies
    Sections
    • Companies Home
    • Energy
    • Financials
    • Health
    • Industrials
    • Media
    • Professional Services
    • Retail & Consumer
    • Tech Sector
    • Telecoms
    • Transport
    Most Read
    • EY rejects TPG plan to break up Big Four firm
    • Carlsberg ‘shocked’ at seizure of Russian subsidiary
    • TPG approaches EY about buying stake in consulting arm
    • Jamie Oliver to steer clear of challenging mid-market in London return
    • EY warns UK staff over pay as it trims jobs
  • Tech
  • Markets
    Sections
    • Markets Home
    • Alphaville
    • Markets Data
    • Cryptofinance
    • Capital Markets
    • Commodities
    • Currencies
    • Equities
    • Fund Management
    • Trading
    • Moral Money
    • ETF Hub
    Most Read
    • Vladimir Putin plans meeting on Russian currency controls after rouble’s slide
    • Live news updates from August 16: UK inflation slows to 6.8%, Fed minutes signal ‘two sided’ risk
    • Ukraine defies Russian threat as container ship leaves Odesa
    • Global investors dump Chinese securities as state support hopes fade
    • Vietnamese EV maker worth more than Ford or GM after US listing
  • Climate
  • Opinion
    Sections
    • Opinion Home
    • Columnists
    • The FT View
    • Lex
    • Obituaries
    • Letters
    Most Read
    • The scourge of climate doomism
    • British neglect risks Northern Ireland’s future
    • Pickleball is redefining retirement in the US
    • Flirting with default, Argentina is turning rightward
    • Today’s investors don’t understand the impact of geopolitics
  • Work & Careers
    Sections
    • Work & Careers Home
    • Business School Rankings
    • Business Education
    • Entrepreneurship
    • Recruitment
    • Business Books
    • Business Travel
    Most Read
    • Corporate America needs to ‘step up’ for trans staff, says former Goldman managing director
    • Business Book of the Year 2023 — the longlist
    • How to manage the climate-conscious worker
  • Life & Arts
    Sections
    • Life & Arts Home
    • Arts
    • Books
    • Food & Drink
    • FT Magazine
    • House & Home
    • Style
    • Travel
    • FT Globetrotter
    Most Read
    • How to spend it in . . . Batroun, north Lebanon
    • How the lives — and sexual freedoms — of Genghis Khan’s Mongolians helped shape a civilisation
    • An ode to the pool: writers on their favourite swimming spots
    • Five stars for the beguiling and demanding role-playing fantasy Baldur’s Gate 3 — review
    • A mind-infecting virus: the dark dreams of QAnon
  • HTSI
  1. Companies
  2. Health
  • Healthcare
  • Pharmaceuticals
MenuSearch
  • Home
  • World
  • UK
  • Companies
  • Tech
  • Markets
  • Climate
  • Opinion
  • Work & Careers
  • Life & Arts
  • HTSI
Financial Times
SubscribeSign In

Health

Add to myFT Digest

Add this topic to your myFT Digest for news straight to your inbox

  • Thursday, 17 August, 2023
    National Health Service
    NHS capital investment cuts leave England’s hospitals crumbling

    St Mary’s in London is an example of how a longtime lack of spending is being felt across the system

  • Wednesday, 16 August, 2023
    National Health Service
    Health leaders welcome new UK cancer targets but warn more ‘resources’ needed

    Expert say altering standards alone will not be enough to improve vital services

  • Wednesday, 16 August, 2023
    Anti-binge-drinking app shown to help students cut down on alcohol

    Game-like programme encouraged heavy drinkers to consume as much as 10% less, say researchers

  • Wednesday, 16 August, 2023
    Medical science
    Transplanted pig kidneys provide ‘life-sustaining’ functions in human for first time

    Successful study advances prospects of xenotransplantation, using engineered organs from animals

  • Wednesday, 16 August, 2023
    Antibiotic resistance
    UK moves to combat antimicrobial resistance with overseas investment

    Health department to spend £210mn to track deadly superbugs across Asia and Africa

  • Tuesday, 15 August, 2023
    Neurotechnology
    Pink Floyd strike a chord as scientists recreate song from brain activity

    ‘Another Brick in the Wall’ study could help people with severe neurological damage to communicate

  • Sunday, 13 August, 2023
    Pilita Clark
    The perils of impenetrable gibberish

    A Hungarian doctor and Donald Trump show why it’s important to get your message across clearly at work

  • Sunday, 13 August, 2023
    Drugs research
    Eli Lilly achieves hard-won success with Alzheimer’s and obesity drugs

    US pharmaceutical group says it wants to become the first trillion dollar healthcare company

  • Sunday, 13 August, 2023
    Healthcare
    Private equity groups bet on UK healthcare as NHS waiting lists grow

    Number of deals in sector hits highest level in a decade despite wider M&A slowdown

  • Saturday, 12 August, 2023
    Isabel Berwick
    Office Therapy: You ask, we answer

    Straight-talking solutions to tricky workplace dilemmas, from the host of the Working It podcast

  • Friday, 11 August, 2023
    The Big Read
    Weight-loss drugs: will health systems and insurers pay for ‘skinny jabs’?

    A new study bolsters the case that semaglutide is not merely a vanity drug but has a key role to play in treating obesity

  • Thursday, 10 August, 2023
    The Big Read
    The dark side of the US sports betting boom

    Americans have bet $245bn on sporting events since restrictions were loosened in 2018. But many fear a surge in gambling addiction is coming

  • Thursday, 10 August, 2023
    News in-depthClimate change
    Third of England’s healthcare facilities at risk from heatwaves by 2050

    Government urged to act to prepare hospitals and care homes for higher temperatures as FT analysis reveals regional vulnerabilities

  • Tuesday, 8 August, 2023
    LexEli Lilly & Co
    Eli Lilly/Novo: come for the weight loss, stay for other health benefits Premium content

    Drugs that tackle obesity, diabetes and heart disease are good for profits and the public

  • Tuesday, 8 August, 2023
    Novo Nordisk AS
    Novo Nordisk’s obesity drug cuts risk of strokes and heart attacks

    Shares in Danish drugmaker and US rival Eli Lilly surge to record highs after positive trial of weight-loss drug

  • Monday, 7 August, 2023
    Antibiotic resistance
    Antibiotic resistance linked to air pollution, study suggests

    Research finds superbugs increase in tandem with levels of small particulate matter in the air

  • Sunday, 6 August, 2023
    News in-depthResearch and development
    UK better prepared for next pandemic, say top scientists

    New vaccines centre supports aim to develop jab for any new potential killer pathogen within 100 days

  • Friday, 4 August, 2023
    HTSI
    Arnold Schwarzenegger: ‘I’m not the sort of person who looks back’

    But with two Netflix shows and a retrospective photobook on the way, the actor, bodybuilder and politician is forcing himself to be reflective

  • Thursday, 3 August, 2023
    National Health Service
    New diagnostic centres to boost NHS testing capacity in England

    Partnership with private sector aimed at cutting waiting lists amid spending constraints

  • Thursday, 3 August, 2023
    Medical science
    Bacteria in mosquito guts trialled as weapon against malaria

    Scientists hail ‘entirely novel approach’ to controlling a disease that kills more than 600,000 a year

  • Thursday, 3 August, 2023
    LexNovo Nordisk AS
    Novo Nordisk/obesity drugs: bullish forecasts will override side effect fears Premium content

    Legal and regulatory actions are more likely to drag on earnings than negate them

  • Wednesday, 2 August, 2023
    Pharmaceuticals sector
    Lawsuit alleges blockbuster weight-loss drugs cause ‘stomach paralysis’

    Novo Nordisk and Eli Lilly accused of failing to warn patients of gastroparesis risk

  • Tuesday, 1 August, 2023
    Pharmaceuticals sector
    Glasgow university spinout raises $43mn to ‘digitise chemistry’

    Chemify’s technology aims to remove bottleneck of producing molecules in the lab

  • Tuesday, 1 August, 2023
    British American Tobacco PLC
    New British American Tobacco chief calls for ‘better’ vaping rules

    Tadeu Marroco admits there are issues such as underage use as many countries adopt tougher stance on e-cigarettes

  • Monday, 31 July, 2023
    Special Report
    Health at Work

    What the Britain’s Healthiest Workplace data tell us about the nation’s wellbeing, as tough economic times beckon. Also: counting the cost of rising long-term sickness on the economy; how organisations can tackle rising levels of exhaustion and retain staff; workspace designers are going all out on domesticity

Previous page You are on page 1 Next page

Be part of FT Community

Discover unmissable flagship events and members only communities to expand your thinking and elevate your career

FT Live
Improving Healthcare Outcomes for Patients in the US
Using digitization to deliver a positive patient experience driving efficiencies
Wednesday, 30th AugustOnline
FT Live
Health Technology Summit
Powering innovation across health systems
Thursday, 30th NovemberOnline
FT Live
US Pharma and Biotech Summit
Exploring trends and innovations in life sciences across the United States
Tuesday, 14th May 2024New York, US & Online
Learn more about FT Community

Useful links

Support

View Site TipsHelp CentreContact UsAbout UsAccessibilitymyFT TourCareers

Legal & Privacy

Terms & ConditionsPrivacy PolicyCookiesCopyrightSlavery Statement & Policies

Services

Share News Tips SecurelyIndividual SubscriptionsProfessional SubscriptionsRepublishingExecutive Job SearchAdvertise with the FTFollow the FT on TwitterFT ChannelsFT Schools

Tools

PortfolioToday's Newspaper (ePaper)Alerts HubBusiness School RankingsEnterprise ToolsNews feedNewslettersCurrency Converter

Community & Events

FT CommunityFT Live EventsFT ForumsFT Board DirectorBoard Director Programme

More from the FT Group

Markets data delayed by at least 15 minutes. © THE FINANCIAL TIMES LTD 2023. FT and ‘Financial Times’ are trademarks of The Financial Times Ltd.
The Financial Times and its journalism are subject to a self-regulation regime under the FT Editorial Code of Practice.
Financial Times

UK Edition

Subscribe for full access
  • Switch to International Edition

Top sections

  • Home
  • World
    • Global Economy
    • UK
    • US
    • China
    • Africa
    • Asia Pacific
    • Emerging Markets
    • Europe
    • War in Ukraine
    • Americas
    • Middle East & North Africa
    • Australia & NZ
  • UK
    • UK Economy
    • UK Politics
    • Brexit
    • UK Companies
    • Personal Finance
  • Companies
    • Energy
    • Financials
    • Health
    • Industrials
    • Media
    • Professional Services
    • Retail & Consumer
    • Tech Sector
    • Telecoms
    • Transport
  • Tech
  • Markets
    • Alphaville
    • Markets Data
    • Cryptofinance
    • Capital Markets
    • Commodities
    • Currencies
    • Equities
    • Fund Management
    • Trading
    • Moral Money
    • ETF Hub
  • Climate
  • Opinion
    • Columnists
    • The FT View
    • Lex
    • Obituaries
    • Letters
  • Work & Careers
    • Business School Rankings
    • Business Education
    • Entrepreneurship
    • Recruitment
    • Business Books
    • Business Travel
  • Life & Arts
    • Arts
    • Books
    • Food & Drink
    • FT Magazine
    • House & Home
    • Style
    • Travel
    • FT Globetrotter
  • Personal Finance
    • Property & Mortgages
    • Investments
    • Pensions
    • Tax
    • Banking & Savings
    • Advice & Comment
    • Next Act
  • HTSI
  • Special Reports

FT recommends

  • Lex
  • Alphaville
  • Lunch with the FT
  • FT Globetrotter
  • #techAsia
  • Moral Money
  • Visual and data journalism
  • Newsletters
  • Video
  • Podcasts
  • News feed
  • FT Live Events
  • FT Forums
  • Board Director Programme
  • myFT
  • Portfolio
  • Today's Newspaper (ePaper)
  • Crossword
  • Our Apps
  • Help Centre
  • Subscribe
  • Sign In